|
시장보고서
상품코드
2051114
핵의학 영상 장비 시장 : 제품 유형별, 용도별, 최종사용자별, 지역별Nuclear Imaging Equipment Market, By Product Type, By Application, By End User, By Geography |
||||||
핵의학 영상 장비 시장은 2026년에 37억 6,000만 달러로 추정되며, 2033년까지 54억 달러에 이를 전망입니다. 또한 2026-2033년 CAGR 5.3%를 기록할 것으로 예측됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 37억 6,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 5.30% | 2033년 시장 규모 예측 : | 54억 달러 |
핵의학은 소량의 방사성 물질을 이용하여 다양한 암, 심장병, 기타 신체 내 특정 질환을 포함한 다양한 질병을 진단하고 치료하는 의료영상진단의 한 분야입니다. 핵의학 영상진단은 장기, 조직 또는 뼈의 기능을 기반으로 의학적 문제의 원인을 파악합니다. 이는 구조적 외형에 따라 질병의 유무를 판단하는 엑스레이, 초음파 또는 기타 진단 검사와는 다른 점입니다. 핵의학 또는 방사성 동위원소 이미징 검사는 의사가 병을 진단하는 데 도움이 되는 비침습적이고 일반적으로 통증이 없는 의료 검사입니다. 이러한 영상 검사에는 방사성의약품 또는 방사성 추적자라고 불리는 방사성 물질이 사용됩니다. 핵의학 검사의 유형에 따라 방사성 추적자는 정맥 주사, 경구 섭취 또는 가스로 흡입하여 검사 대상 장기나 신체 부위에 축적되어 감마선 형태로 에너지를 방출합니다. 이 에너지는 감마 카메라, 양전자방출단층촬영(PET) 스캐너 및/또는 프로브라고 불리는 장치를 통해 감지됩니다.
시장 역학
세계적으로 다양한 암의 유병률이 증가함에 따라 예측 기간 동안 시장 성장을 가속할 것으로 예측됩니다. 또한, 연구개발(R&:D)의 활성화와 시장 기업들의 신제품 출시 증가도 예측 기간 동안 시장 성장에 기여할 것입니다. 예를 들어, 미국 암협회가 2022년 2월 4일 발표한 자료에 따르면, 2021년 전 세계적으로 약 1,930만 건의 신규 암 발병과 1,000만 건의 암 사망이 발생했다고 합니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 핵의학 영상 장비 시장 : 제품 유형별, 2021년-2033년
제5장 핵의학 영상 장비 시장 : 용도별, 2021년-2033년
제6장 핵의학 영상 장비 시장 : 최종사용자별, 2021년-2033년
제7장 핵의학 영상 장비 시장 : 지역별, 2021년-2033년
제8장 경쟁 구도
제9장 섹션
LSH 26.06.17Nuclear Imaging Equipment Market is estimated to be valued at USD 3.76 Bn in 2026 and is expected to reach USD 5.40 Bn by 2033, growing at a compound annual growth rate (CAGR) of 5.3% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 3.76 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 5.30% | 2033 Value Projection: | USD 5.40 Bn |
Nuclear medicine is a branch of medical imaging that uses small amounts of radioactive material to diagnose or treat a variety of diseases, including many types of cancers, heart disease and certain other abnormalities within the body. Nuclear imaging determines the cause of the medical problem based on the function of the organ, tissue or bone. This is how nuclear imaging differs from an X-ray, ultrasound or any other diagnostic test that determines the presence of disease based on structural appearance. Nuclear medicine or radionuclide imaging procedures are noninvasive and usually painless medical tests that help physicians diagnose medical conditions. These imaging scans use radioactive materials called radiopharmaceuticals or radiotracers. Depending on the type of nuclear medicine exam are done, the radiotracer is either injected into a vein, swallowed or inhaled as a gas and eventually accumulates in the organ or area of your body being examined, where it gives off energy in the form of gamma rays. This energy is detected by a device called a gamma camera, a (positron emission tomography) PET scanner and/or probe.
Market Dynamics
Increasing prevalence of various cancers globally is expected to propel the market growth over the forecast period. Moreover, increasing research and development (R&D) and increasing product launches by the market players will aid in the market growth over the forecast period. For instance, according to the data published by the American Cancer Society on February 4, 2022, worldwide, an estimated 19.3 Mn new cancer cases and 10 Mn cancer deaths occurred in 2021.
Market Segmentation
- Product Type Insights (Revenue, USD Bn, 2021 - 2033)
- Single Photon Emission Computed Tomography (SPECT)
- Positron Emission Tomography (PET)
- Hybrid PET-CT
- Hybrid SPECT-CT
- Hybrid PET-MRI
- Others
- Application Insights (Revenue, USD Bn, 2021 - 2033)
- Oncology
- Cardiology
- Neurology
- Others
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Hospitals and clinics
- Diagnostic imaging centers
- Research institutes
- Others
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- GE Healthcare
- Siemens Healthineers
- Philips Healthcare
- Canon Medical Systems
- Mediso Medical Imaging Systems
- MIE America
- DDD Diagnostic
- Segami
- Digirad
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Application
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Increasing incidence of cancer & cardiac disease
- Technological advancements in imaging modalities
- Restraint
- High cost of nuclear imaging modalities
- Opportunity
- Hybrid imaging modalities
- Key Highlights
- Regulatory Scenario
- Recent Trends
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Mergers, Acquisitions, and Collaborations
- Drivers
4. Nuclear Imaging Equipment Market, By Product Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Single Photon Emission Computed Tomography (SPECT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Positron Emission Tomography (PET)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Hybrid PET-CT
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Hybrid SPECT-CT
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Hybrid PET-MRI
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Nuclear Imaging Equipment Market, By Application, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Cardiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Nuclear Imaging Equipment Market, By End User, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Hospitals and clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Diagnostic imaging centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Research institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Nuclear Imaging Equipment Market, By Region, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2033
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- U.K.
- Germany
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- China
- Japan
- India
- Australia
- ASEAN
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Bn)
- South Africa
- North Africa
- Central Africa
8. Competitive Landscape
- Company Profile
- GE Healthcare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Siemens Healthineers
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Philips Healthcare
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Canon Medical Systems
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Mediso Medical Imaging Systems
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- MIE America
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- DDD Diagnostic
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Segami
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Digirad
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
- GE Healthcare
9. Section
- References
- Research Methodology
- About Us
